Cargando…

Comparative efficacy of various CHIs combined with western medicine for non-small cell lung cancer: A bayesian network meta-analysis of randomized controlled trials

Background: Given the limitations of Western medicine (WM) for the treatment of non-small cell lung cancer (NSCLC) and the wide exploration of Chinese herbal injections (CHIs), systematically evaluate the efficacy of Various CHIs Combined with WM for Non-small Cell Lung Cancer. In this study, we per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Ciyan, Chen, Jing, Cui, Wei, Li, Sini, Li, Jianhe, Peng, Liubao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686447/ https://www.ncbi.nlm.nih.gov/pubmed/36438813 http://dx.doi.org/10.3389/fphar.2022.1037620

Ejemplares similares

Cost-Effectiveness of Frontline Treatment for Advanced Renal Cell Carcinoma in the Era of Immunotherapies
por: Li, SiNi, et al.
Publicado: (2021)

Cost-Effectiveness of Nivolumab Plus Cabozantinib Versus Sunitinib as a First-Line Treatment for Advanced Renal Cell Carcinoma in the United States
por: Li, SiNi, et al.
Publicado: (2021)

Cost-Effectiveness of Bevacizumab Biosimilar LY01008 Combined With Chemotherapy as First-Line Treatment for Chinese Patients With Advanced or Recurrent Nonsquamous Non-Small Cell Lung Cancer
por: Luo, Xia, et al.
Publicado: (2022)

CHIS
por: CERN. Geneva
Publicado: (2011)

Cost-Effectiveness of Lorlatinib as a First-Line Therapy for Untreated Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer
por: Li, SiNi, et al.
Publicado: (2021)

Cost-Effectiveness of First-Line Versus Second-Line Pembrolizumab or Chemotherapy in Patients With Microsatellite-Instability-High/Mismatch Repair-Deficient Advanced Colorectal Cancer
por: Chongqing, Tan, et al.
Publicado: (2021)

CHIS Communications
por: Department, HR
Publicado: (2011)

CHIS - Information Note 2 CHIS - Note d'information 2
por: Matheys, Jean-Pol
Publicado: (2019)

Sintilimab Plus Bevacizumab Biosimilar Versus Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
por: Peng, Ye, et al.
Publicado: (2022)

Efficacy and safety of combined Chinese and Western medicine in the treatment of knee osteoarthritis: a prospective, multicenter cohort study
por: Ye, Qian-Yun, et al.
Publicado: (2023)

CHIS - Information Notes
por: Department, HR
Publicado: (2014)

News from CHIS
Publicado: (2014)

Introductory information - CHIS
por: Matheys, Jean-Pol
Publicado: (2018)

The Safety and Efficacy of Camrelizumab and Its Combination With Apatinib in Various Solid Cancers
por: Wang, Kunlun, et al.
Publicado: (2020)

CHIS - Directive d'application CHIS/D/02 - Restitution de l'indu
por: Matheys, Jean-Pol
Publicado: (2019)

Comparative efficacy and safety of Chinese medicine injections combined with capecitabine and oxaliplatin chemotherapies in treatment of colorectal cancer: A bayesian network meta-analysis
por: Liu, Shuzhen, et al.
Publicado: (2022)

Cost-effectiveness of Triple Therapy vs. Biologic Treatment Sequence as First-line Therapy for Rheumatoid Arthritis Patients after Methotrexate Failure
por: Li, SiNi, et al.
Publicado: (2021)

Cost-Effectiveness of Baricitinib for Patients with Moderate-to-Severe Rheumatoid Arthritis After Methotrexate Failed in China
por: Li, SiNi, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab for Advanced Non-Small-Cell Lung Cancer
por: Wan, Xiaomin, et al.
Publicado: (2021)

Chinese herbal medicine combined with western medicine for the treatment of type 2 diabetes mellitus with hyperuricemia: A systematic review and meta-analysis
por: Liu, Hongyan, et al.
Publicado: (2023)

CHIS - APPROVED HEALTH CARE PROVIDERS 2021 CHIS- PRESTATAIRES DE SOINS AGRÉÉS 2021
por: Department, HR
Publicado: (2017)

Efficacy and safety of Keluoxin capsule in combination with Western medicine for diabetic kidney disease: A systematic review and meta-analysis
por: Zhang, Wenhua, et al.
Publicado: (2023)

Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China
por: Li, Sini, et al.
Publicado: (2020)

Evidence Mapping of 23 Systematic Reviews of Traditional Chinese Medicine Combined With Western Medicine Approaches for COVID-19
por: Zhang, Ting, et al.
Publicado: (2022)

Traditional Chinese Medicine Oral Liquids Combined With Azithromycin for Mycoplasma pneumoniae Pneumonia in Children: A Bayesian Network Meta-Analysis
por: Chen, Zhe, et al.
Publicado: (2021)

The comparative effects of oral Chinese patent medicines combined with western medicine in stable angina: A systematic review and network meta-analysis of 179 trials
por: Huang, Peiying, et al.
Publicado: (2022)

First-Line ICI Monotherapies for Advanced Non-small-cell Lung Cancer Patients With PD-L1 of at Least 50%: A Cost-Effectiveness Analysis
por: Liu, Qiao, et al.
Publicado: (2021)

CHIS - Information Note n°6
por: Matheys, Jean-Pol
Publicado: (2019)

CHIS - Declaration of non-occupational accident
por: Department, HR
Publicado: (2014)

CHIS - Long Term Care (LTC)
por: Department, HR
Publicado: (2010)

CHIS: Information UNIQA Assistance-Telemedicine
por: TPA, UNIQA
Publicado: (2015)

The combination of Chinese and Western Medicine in the management of rheumatoid arthritis: A real-world cohort study across China
por: Zhong, Linda LD., et al.
Publicado: (2022)

The Bone-Protecting Efficiency of Chinese Medicines Compared With Western Medicines in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Comparative Studies
por: Cai, Xiao, et al.
Publicado: (2018)

CHIS - Directive d'application CHIS/D/03 - Versement Direct de Prestations aux Conjoints Membres Subsidiaires
por: Matheys, Jean-Pol
Publicado: (2019)

The efficacy and safety of mecobalamin combined with Chinese medicine injections in the treatment of diabetic peripheral neuropathy: A systematic review and Bayesian network meta-analysis of randomized controlled trials
por: Ma, Yuqi, et al.
Publicado: (2022)

Comparative Analysis of the Efficacy and Safety of Different Traditional Chinese Medicine Injections in the Treatment of Cancer-Related Pain: A Bayesian Network Meta-Analysis
por: Su, Pengli, et al.
Publicado: (2022)

CHIS/F04 - Request for advance reimbursement
por: CERN Healht Insurance Scheme, CHIS
Publicado: (2015)

Los talleres líticos de Aguacatenango, Chis. /
por: Guevara Sánchez, Arturo
Publicado: (1981)

The Effect of Chinese Herbal Medicine Combined With Western Medicine on Vascular Endothelial Function in Patients With Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Ren, Weiquan, et al.
Publicado: (2020)

The Effects of Salvianolate Combined With Western Medicine on Diabetic Nephropathy: A Systematic Review and Meta-Analysis
por: Shen, Yuehong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t5tj032urnrpr1e1qm11krq5hs